Published in World J Psychiatry on September 22, 2016
From inflammation to sickness and depression: when the immune system subjugates the brain. Nat Rev Neurosci (2008) 15.90
Inflammatory blockade restores adult hippocampal neurogenesis. Science (2003) 10.14
The inflammatory reflex. Nature (2002) 9.10
A meta-analysis of cytokines in major depression. Biol Psychiatry (2009) 7.16
Altered pituitary-adrenal axis responses to provocative challenge tests in adult survivors of childhood abuse. Am J Psychiatry (2001) 4.36
Cytokines for psychologists: implications of bidirectional immune-to-brain communication for understanding behavior, mood, and cognition. Psychol Rev (1998) 3.66
The HPA axis in major depression: classical theories and new developments. Trends Neurosci (2008) 3.47
Neurobehavioral effects of interferon-alpha in cancer patients: phenomenology and paroxetine responsiveness of symptom dimensions. Neuropsychopharmacology (2002) 3.24
IL-1beta is an essential mediator of the antineurogenic and anhedonic effects of stress. Proc Natl Acad Sci U S A (2008) 3.19
Cytokines and major depression. Prog Neuropsychopharmacol Biol Psychiatry (2005) 3.00
Cytokines and the brain: implications for clinical psychiatry. Am J Psychiatry (2000) 2.96
Brain inflammation and adult neurogenesis: the dual role of microglia. Neuroscience (2008) 2.84
Involvement of pro- and anti-inflammatory cytokines and chemokines in the pathophysiology of traumatic brain injury. Neurotherapeutics (2010) 2.52
Antidepressant effects of selective serotonin reuptake inhibitors (SSRIs) are attenuated by antiinflammatory drugs in mice and humans. Proc Natl Acad Sci U S A (2011) 2.37
Evidence for an immune response in major depression: a review and hypothesis. Prog Neuropsychopharmacol Biol Psychiatry (1995) 2.35
The effect of antidepressant medication treatment on serum levels of inflammatory cytokines: a meta-analysis. Neuropsychopharmacology (2011) 2.15
Activation of central nervous system inflammatory pathways by interferon-alpha: relationship to monoamines and depression. Biol Psychiatry (2008) 1.96
The corticotropin-releasing factor (CRF) hypothesis of depression: new findings and new directions. Mol Psychiatry (1996) 1.95
Functional polymorphisms in the interleukin-6 and serotonin transporter genes, and depression and fatigue induced by interferon-alpha and ribavirin treatment. Mol Psychiatry (2008) 1.80
Immune modulation of the hypothalamic-pituitary-adrenal (HPA) axis during viral infection. Viral Immunol (2005) 1.63
Kynurenine pathway in major depression: evidence of impaired neuroprotection. J Affect Disord (2006) 1.58
Cytokine production in major depressed patients before and after clomipramine treatment. Biol Psychiatry (1994) 1.58
Tryptophan depletion and emotional processing in healthy volunteers at high risk for depression. Biol Psychiatry (2011) 1.51
Cytokines and the central nervous system. Brain Res Bull (2001) 1.49
Interleukin-1 (IL-1): a central regulator of stress responses. Front Neuroendocrinol (2008) 1.46
Cytokines, stress and depressive illness: brain-immune interactions. Ann Med (2003) 1.44
Glutamatergic modulators: the future of treating mood disorders? Harv Rev Psychiatry (2010) 1.42
Cerebrospinal fluid corticotropin-releasing factor and perceived early-life stress in depressed patients and healthy control subjects. Neuropsychopharmacology (2004) 1.41
Low levels of circulating inflammatory cytokines--do they affect human brain functions? Brain Behav Immun (2002) 1.38
Cytokine activation of the HPA axis. Ann N Y Acad Sci (2000) 1.38
The cytokine hypothesis of depression: inflammation, oxidative & nitrosative stress (IO&NS) and leaky gut as new targets for adjunctive treatments in depression. Neuro Endocrinol Lett (2008) 1.37
Regulation of cytokine and cytokine receptor expression by glucocorticoids. J Leukoc Biol (1996) 1.34
Inflammation, glutamate, and glia in depression: a literature review. CNS Spectr (2008) 1.33
A psychoneuroimmunological review on cytokines involved in antidepressant treatment response. Hum Psychopharmacol (2010) 1.30
Th1, Th2, and Th3 cytokine alterations in major depression. J Affect Disord (2005) 1.29
A potential role for pro-inflammatory cytokines in regulating synaptic plasticity in major depressive disorder. Int J Neuropsychopharmacol (2009) 1.28
Association of depressive disorders, depression characteristics and antidepressant medication with inflammation. Transl Psychiatry (2012) 1.22
The proinflammatory cytokine, interleukin-1alpha, reduces glucocorticoid receptor translocation and function. Endocrinology (1999) 1.21
Cytokine-specific central monoamine alterations induced by interleukin-1, -2 and -6. Brain Res (1994) 1.20
Steroid-independent translocation of the glucocorticoid receptor by the antidepressant desipramine. Mol Pharmacol (1997) 1.20
Interleukin 1 receptors in the brain and endocrine tissues. Immunol Today (1993) 1.18
Cytokines and their receptors in the central nervous system: physiology, pharmacology, and pathology. Pharmacol Ther (1996) 1.17
Associations of anti-hypertensive treatments with Alzheimer's disease, vascular dementia, and other dementias. J Alzheimers Dis (2011) 1.13
Intracerebroventricular interleukin-1 receptor antagonist blocks the enhancement of fear conditioning and interference with escape produced by inescapable shock. Brain Res (1995) 1.13
Celecoxib as an adjunct in the treatment of depressive or mixed episodes of bipolar disorder: a double-blind, randomized, placebo-controlled study. Hum Psychopharmacol (2008) 1.10
HPA and immune axes in stress: involvement of the serotonergic system. Neuroimmunomodulation (2007) 1.10
Suppression of cell proliferation by interferon-alpha through interleukin-1 production in adult rat dentate gyrus. Neuropsychopharmacology (2006) 1.09
The concept of depression as a dysfunction of the immune system. Curr Immunol Rev (2010) 1.06
Regulation of the human serotonin transporter by interleukin-1 beta. Biochem Biophys Res Commun (1995) 1.03
The role of IL-12 and TGF-beta1 in the pathophysiology of major depressive disorder. Int Immunopharmacol (2006) 1.01
Incidence and clinical course of major depression in patients with chronic hepatitis type C undergoing interferon-alpha therapy: a prospective study. Gen Hosp Psychiatry (2003) 1.01
Are omega-3 fatty acids antidepressants or just mood-improving agents? The effect depends upon diagnosis, supplement preparation, and severity of depression. Mol Psychiatry (2012) 1.00
Effect of quinolinic acid on human astrocytes morphology and functions: implications in Alzheimer's disease. J Neuroinflammation (2009) 1.00
Network beyond IDO in psychiatric disorders: revisiting neurodegeneration hypothesis. Prog Neuropsychopharmacol Biol Psychiatry (2013) 0.99
TNF-alpha as a molecular target in bipolar disorder. Prog Neuropsychopharmacol Biol Psychiatry (2008) 0.99
The inflammatory response system and the availability of plasma tryptophan in patients with primary sleep disorders and major depression. J Affect Disord (1998) 0.98
Effects of cytokines on glucocorticoid receptor expression and function. Glucocorticoid resistance and relevance to depression. Adv Exp Med Biol (1999) 0.97
Antidepressant-like effects of CP-154,526, a selective CRF1 receptor antagonist. Eur J Pharmacol (1997) 0.96
Catecholamine effects upon rat hypothalamic corticotropin-releasing hormone secretion in vitro. J Clin Invest (1988) 0.95
The cytokine-HPA axis feed-back circuit. Z Rheumatol (2000) 0.94
Cytokines, prostaglandins and nitric oxide in the regulation of stress-response systems. Pharmacol Rep (2013) 0.94
Inflammation and depression: is there a causal connection with dementia? Neurotox Res (2006) 0.89
Prolonged desipramine treatment increases the production of interleukin-10, an anti-inflammatory cytokine, in C57BL/6 mice subjected to the chronic mild stress model of depression. J Affect Disord (2001) 0.86
Induction of cytokine synthesis and fever suppresses REM sleep and improves mood in patients with major depression. Biol Psychiatry (1995) 0.85
Cultured sympathetic neurons synthesize and release the cytokine interleukin 1 beta. Proc Natl Acad Sci U S A (1992) 0.85
Dynamic regulation of proinflammatory cytokines. Adv Exp Med Biol (1999) 0.84
Localization of interleukin-1 beta converting enzyme mRNA in rat brain vasculature: evidence that the genes encoding the interleukin-1 system are constitutively expressed in brain blood vessels. Pathophysiological implications. Neuroimmunomodulation (1996) 0.84
Effects of interferon-gamma, interleukin-1 beta, and tumor necrosis factor-alpha on the serotonin metabolism in the nucleus raphe dorsalis of the rat. J Neural Transm (Vienna) (1997) 0.82
Non-steroidal anti-inflammatory drugs and efficacy of antidepressants in major depressive disorder. Psychol Med (2012) 0.80
Acetylsalicylic acid as an augmentation agent in fluoxetine treatment resistant depressive rats. Neurosci Lett (2011) 0.80
Can inflammation be an independent predictor of depression? Brain Behav Immun (2009) 0.79
Questions raised by the cytokine hypothesis of depression. Brain Behav Immun (2002) 0.78
Role of corticotropin-releasing factor in immunosuppression. Trans Assoc Am Physicians (1991) 0.77
Induction of interleukin-1 beta and interleukin-1 receptor antagonist mRNA by chronic treatment with various psychotropics in widespread area of rat brain. Neurosci Lett (1996) 0.77
Neurotherapeutic implications of brain-immune interactions. Neuropsychopharmacology (2014) 0.76